FDA approved the use of a new prefilled syringe Norditropin
FDA approved the use of a new prefilled syringe Norditropin FlexPro
The U.S. Food and Drug Administration (FDA) approved the use of a new prefilled syringe Norditropin FlexPro made by a pharmaceutical company Novo Nordisk AS. The syringe is designed for the introduction of growth hormone Norditropin (somatropin) in children and adults.
The disposable prefilled syringe Norditropin FlexPro is equipped with a new metering mechanism, and its modern design facilitates the training and use by patients. In addition, it is equipped with a sound indicator of dosing. The use of this prefilled syringe requires to use cartridges. Norditropin FlexPro is available in 3 different doses: 5 mg / 1,5 ml, 10 mg / 1,5 ml and 15 mg / 1,5 ml.